MX2010001584A - Tratamiento o prevencion de infeccion por rotavirus. - Google Patents

Tratamiento o prevencion de infeccion por rotavirus.

Info

Publication number
MX2010001584A
MX2010001584A MX2010001584A MX2010001584A MX2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A MX 2010001584 A MX2010001584 A MX 2010001584A
Authority
MX
Mexico
Prior art keywords
treating
rotavirus infection
preventing rotavirus
preventing
cla
Prior art date
Application number
MX2010001584A
Other languages
English (en)
Inventor
Alastair Kenneth Hugh Macgibbon
Michelle Avril Mcconnel
Clare Elizabeth Ann Fitzpatrick
Glenn Stuart Buchan
Original Assignee
Fonterra Co Operative Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fonterra Co Operative Group filed Critical Fonterra Co Operative Group
Publication of MX2010001584A publication Critical patent/MX2010001584A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2230/00—Aspects relating to animal feed or genotype
    • A23C2230/10—Animal milk with modified composition due to a specific feed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Husbandry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe el uso de uno o más del ácido linoleico conjugado (CLA), grasa de leche alta en CLA, o una o más composiciones lipídicas de leche bovina para tratar o prevenir la infección por rotavirus.
MX2010001584A 2007-08-09 2008-08-08 Tratamiento o prevencion de infeccion por rotavirus. MX2010001584A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ560524A NZ560524A (en) 2007-08-09 2007-08-09 Treating or preventing rotavirus infection using conjugated linoleic acid
PCT/NZ2008/000199 WO2009020405A1 (en) 2007-08-09 2008-08-08 Treating or preventing rotavirus infection

Publications (1)

Publication Number Publication Date
MX2010001584A true MX2010001584A (es) 2010-03-15

Family

ID=40341525

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001584A MX2010001584A (es) 2007-08-09 2008-08-08 Tratamiento o prevencion de infeccion por rotavirus.

Country Status (14)

Country Link
US (1) US20110300229A1 (es)
EP (1) EP2173364B1 (es)
CN (1) CN102159223B (es)
AU (1) AU2008284504A1 (es)
BR (1) BRPI0814935A2 (es)
CA (1) CA2696035A1 (es)
DK (1) DK2173364T3 (es)
ES (1) ES2699084T3 (es)
HK (1) HK1160788A1 (es)
MX (1) MX2010001584A (es)
NZ (2) NZ560524A (es)
RU (1) RU2493860C2 (es)
TW (1) TW200916093A (es)
WO (1) WO2009020405A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101902918A (zh) * 2007-10-19 2010-12-01 方塔拉合作集团有限公司 保持或增加成长或认知发育的方法
WO2010026229A1 (en) * 2008-09-05 2010-03-11 Molkerei Meggle Wasserburg Gmbh & Co. Kg Composition richly containing polar lipid and method of manufacturing the same
EP2389952A1 (en) * 2010-05-31 2011-11-30 Rotalactis Srl Lactadherin-derived peptides as antiviral agents
CN103262893B (zh) * 2013-06-13 2014-11-05 俞祖勋 一种改善智力的配方奶粉
SE537951C2 (sv) * 2013-07-01 2015-12-01 Hero Ag Profylaktisk användning av modersmjölksersättning mot otit
GB201611365D0 (en) * 2016-06-30 2016-08-17 Devenish Nutrition Ltd A composition for use in treating rotavirus infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
CN1787829B (zh) * 2003-03-14 2010-06-16 明治乳业株式会社 抗轮状病毒感染的组合物及制备该组合物的方法
AU2005239968B2 (en) * 2004-05-11 2009-12-03 Auckland Uniservices Limited CLA-enriched milkfat and uses thereof
IN2012DN02664A (es) * 2004-10-12 2015-09-11 Fonterra Co Operative Group
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof

Also Published As

Publication number Publication date
NZ560524A (en) 2011-04-29
BRPI0814935A2 (pt) 2015-02-03
CA2696035A1 (en) 2009-02-12
DK2173364T3 (en) 2018-12-17
NZ586798A (en) 2012-03-30
RU2493860C2 (ru) 2013-09-27
AU2008284504A1 (en) 2009-02-12
RU2010108285A (ru) 2011-09-20
ES2699084T3 (es) 2019-02-07
EP2173364A1 (en) 2010-04-14
EP2173364A4 (en) 2010-11-24
US20110300229A1 (en) 2011-12-08
CN102159223A (zh) 2011-08-17
CN103479607A (zh) 2014-01-01
HK1160788A1 (en) 2012-08-17
CN102159223B (zh) 2013-10-30
WO2009020405A1 (en) 2009-02-12
TW200916093A (en) 2009-04-16
EP2173364B1 (en) 2018-10-31

Similar Documents

Publication Publication Date Title
PH12016500216A1 (en) Stable pharmaceutical composition and methods of using same
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
MY158504A (en) Fatty acid niacin conjugates and their uses
EA201000322A1 (ru) Композиции и способы для обработки семян
MX2020004099A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
MX2009007266A (es) Formulaciones estables de acido s-(+)-abscisico liquidas y de granulo soluble.
MX2011007930A (es) Conjugados de insulina cristalina.
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
MX2009003911A (es) Formulaciones de liberacion inmediata, mejoradas de topiramato.
EP2464724A4 (en) COMPOSITIONS AND METHODS FOR IMPLANTATION OF TREATED ADIPOSE TISSUE AND TREATED ADIPOSE TISSUE PRODUCTS
PH12013502370A1 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
UA109112C2 (uk) Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями
MX350869B (es) Aceleracion de la recuperacion muscular despues de la atrofia muscular inducida por inmovilizacion.
MX2010001584A (es) Tratamiento o prevencion de infeccion por rotavirus.
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
GB2483419A (en) Formulations for the treatment of deep tissue pain
MX369699B (es) Ácido graso del aceite de bogol para uso en suplementos y composiciones de tratamiento y piensos para animales.
MY148276A (en) Long-term feed- elderly
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
MX2009011577A (es) Composiciones y metodos para distribucion de domperidona a traves de la mucosa.
IN2012DN03187A (es)
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
EP2579863A4 (en) COMPOUNDS FOR THE TREATMENT OF BOVINE MASTITIS
MX2012004282A (es) Composiciones farmaceuticas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal